高级检索
当前位置: 首页 > 详情页

Safranal, an active constituent of saffron, ameliorates myocardial ischemia via reduction of oxidative stress and regulation of Ca2+ homeostasis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Univ Chinese Med, Sch Pharm, Shijiazhuang 050200, Hebei, Peoples R China [2]Hebei Univ Chinese Med, Sch Basic Med, Shijiazhuang 050200, Hebei, Peoples R China [3]Hebei Univ Chinese Med, Affiliated Hosp, Shijiazhuang 050011, Hebei, Peoples R China [4]Hebei Med Univ, Dept Pharm, Hosp 4, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China [5]Hebei Key Lab Chinese Med Res Cardiocerebrovasc D, Shijiazhuang 050200, Hebei, Peoples R China
出处:
ISSN:

关键词: Safranal Myocardial ischemia Oxidative stress Cell contractility L-type Ca2+ current

摘要:
Safranal (SFR) is the major constituent of saffron. The purpose of this study was to observe the effect of SFR on myocardial ischemia induced by isoprenaline (ISO) and to explore its possible mechanism. The myocardial ischemia rat model was established by subcutaneous injection of ISO (85 mg/kg/d) on the 8th and 9th day of the experiment. Serum creatine kinase (CK), lactate dehydrogenase (LDH), malondialdehyde (MDA) and superoxide dismutase (SOD) were measured, as were changes in calcium concentration, reactive oxygen species (ROS) and cardiac morphology of the myocardial tissue. The effects of SFR on cell contraction, Ca2+ transient and L-type Ca2+ current (ICa-L) in isolated rat myocardial cells were measured using the Ion Optix detection system and the whole-cell patch-clamp technique. SFR can decrease the activity of serum CK, LDH and MDA, and increase the activity of serum SOD, reduce intracellular calcium concentration and the manufacture of ROS. In addition, SFR can improve changes in heart morphology. SFR can significantly inhibit contraction, Ca2+ transients and ICa-L in isolated ventricular myocytes. SFR has a cardioprotective role in ISO-induced MI rats, and the underling mechanism is related to the inhibition of oxidative stress, myocardial contractility, ICa-L and the regulation of Ca2+ homeostasis. (C) 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2020]版:
大类 | 3 区 医学
小类 | 3 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 药学
JCR分区:
出版当年[2020]版:
Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q2 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [2]Hebei Univ Chinese Med, Sch Basic Med, Shijiazhuang 050200, Hebei, Peoples R China
通讯作者:
通讯机构: [2]Hebei Univ Chinese Med, Sch Basic Med, Shijiazhuang 050200, Hebei, Peoples R China [3]Hebei Univ Chinese Med, Affiliated Hosp, Shijiazhuang 050011, Hebei, Peoples R China [5]Hebei Key Lab Chinese Med Res Cardiocerebrovasc D, Shijiazhuang 050200, Hebei, Peoples R China [*1]School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号